search
CAR T therapy
Trends
- 1CAR T cell therapy shows two years free of lupus flares●Two years later, CAR T cell therapy shows promise for life without lupus flares
Researchers at UMass Chan Medical School report that lupus patients treated with CAR T cell therapy have remained free of disease flares two years after receiving the one-time cell-based treatment. The therapy, originally developed for blood cancers, reprograms a patient's own immune cells, and the latest follow-up data suggest it may offer lasting remission in autoimmune disease.
- 2CAR-T Therapy Expands From Cancer to Autoimmune Diseases●Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases
Researchers at Yale School of Medicine are exploring how CAR-T cell therapy, originally developed to treat blood cancers, could be adapted to treat autoimmune diseases. The approach engineers a patient's immune cells to target disease-causing cells, and scientists are now studying its potential against conditions where the immune system attacks the body itself.